Gandeeva Therapeutics

Gandeeva is a precision biotechnology company harnessing the power of cryogenic electron microscopy (cryo-EM) and machine learning to develop novel therapeutics at an accelerated pace. Gandeeva's mission is to bring new treatment options to patients by revolutionizing drug discovery. Gandeeva Therapeutics was founded in 2021 by Sriram Subramaniam. The company is headquartered in Vancouver, British Columbia, Canada. Gandeeva’s end-to-end platform combines prediction and experimentation to enable breakthroughs in precision medicine by visualizing and analyzing protein-drug interactions at unprecedented speed and in atomic detail. Gandeeva’s unique and world-leading AI-enabled cryo-EM drug discovery platform combines deep biochemical and structural knowledge of the most important protein sites for targeting with tools to cast precision spotlights that translate this knowledge into better, faster and cheaper treatments for patients. Gandeeva's proprietary platform combines breakthrough technologies across chemistry, biology, imaging and machine learning to visualize, measure and capture protein-drug interactions at atomic resolution. Gandeeva has raised $40M in a Series A funding on Jan 31, 2022. The round was led by Lux Capital and Leaps by Bayer, with participation from Obvious Ventures, Amgen Ventures, Amplitude Ventures and Air Street Capital.

Created on 2022-03-29